热门资讯> 正文

Akoustis Technology首席执行官Jeffery Shaly辞职

2024-08-08 20:48

Aktis Oncology, Inc.(AKTS) 0

Akoustis Technologies (NASDAQ:AKTS) has announced the resignation of Jeffery Shealy as chief executive officer and a member of the board of directors, effective August 6, 2024.
Chief Product Officer Kamran Cheema will serve as interim CEO.

More on Akoustis Technologies

Akoustis Technologies, Inc. (AKTS) Q3 2024 Earnings Call Transcript
Akoustis secures $8M in volume XBAW orders with Tier-1 customer
Akoustis stock rallies on $10M registered direct offering priced at-the-market
Seeking Alpha’s Quant Rating on Akoustis Technologies
Historical earnings data for Akoustis Technologies

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。